Prospective Attitudes towards Respiratory Syncytial Virus (RSV) Vaccination : Validation of a Survey Instrument among Young Females in Jordan Pending Vaccine Authorization
In May 2023, the U.S. FDA advisors endorsed Pfizer’s pregnancy-administered vaccine (branded ABRYSVO) to protect infants from respiratory syncytial virus (RSV) infection. Vaccination can reduce the burden of RSV-related respiratory disease, with previous studies showing its substantial medical and financial burden in Jordan. However, pregnant women may exhibit hesitancy to get vaccinated due to co